The meta-analysis result suggested that the frequency of DAPK promoter methylation in patients with HNSCC was significantly higher than the corresponding controls (Fig 2).Therefore, we also assessed the association between DAPK promoter methylation and the clinicopathological features. Here, DAPK1 is linked to head and neck squamous cell carcinoma.